EGLBX
Price
$29.15
Change
+$0.23 (+0.80%)
Updated
Nov 12 closing price
Net Assets
168.27M
VTIAX
Price
$40.68
Change
+$0.20 (+0.49%)
Updated
Nov 12 closing price
Net Assets
554.27B
Interact to see
Advertisement

EGLBX vs VTIAX

Header iconEGLBX vs VTIAX Comparison
Open Charts EGLBX vs VTIAXBanner chart's image
Elfun International Equity
Price$29.15
Change+$0.23 (+0.80%)
VolumeN/A
Net Assets168.27M
Vanguard Total Intl Stock Index Admiral
Price$40.68
Change+$0.20 (+0.49%)
VolumeN/A
Net Assets554.27B
EGLBX vs VTIAX Comparison Chart in %
View a ticker or compare two or three
VS
EGLBX vs. VTIAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EGLBX is a Buy and VTIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 554B vs. EGLBX (168M). VTIAX pays higher dividends than EGLBX: VTIAX (2.70) vs EGLBX (1.39). EGLBX was incepted earlier than VTIAX: EGLBX (38 years) vs VTIAX (15 years). EGLBX (0.38) is less costly to investors than VTIAX (0.09). EGLBX is a more actively managed with annual turnover of: 12.00 vs. VTIAX (3.00). EGLBX has a lower initial minimum investment than VTIAX: EGLBX (500) vs VTIAX (3000). VTIAX annual gain was more profitable for investors over the last year : 25.12 vs. EGLBX (13.99). VTIAX return over 5 years is better than : 39.59 vs. EGLBX (28.73).
EGLBXVTIAXEGLBX / VTIAX
Total Expense Ratio0.380.09422%
Annual Report Gross Expense Ratio0.380.09422%
Fund Existence38 years15 years-
Gain YTD21.40828.91274%
Front LoadN/AN/A-
Min. Initial Investment500300017%
Min. Initial Investment IRAN/AN/A-
Net Assets168M554B0%
Annual Yield % from dividends1.392.7051%
Returns for 1 year13.9925.1256%
Returns for 3 years37.5549.2876%
Returns for 5 years28.7339.5973%
Returns for 10 years72.0779.3591%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRV2.280.21
+10.14%
Acrivon Therapeutics
MRNA26.710.30
+1.14%
Moderna
EGHAU10.55N/A
N/A
EGH Acquisition Corp.
RAMP30.46-0.42
-1.36%
LiveRamp Holdings
IMRX6.62-0.12
-1.78%
Immuneering Corp